Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-05-22

FDA Approved: CYPROHEPTADINE HYDROCHLORIDE — Original Application (QUAGEN PHARMACEUTICALS LLC)

View source ↗

Summary

FDA approved Cyproheptadine hydrochloride from Quagen Pharmaceuticals LLC under an Original Application for a generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cyproheptadine hydrochloride (cyproheptadine)

Snippet

ORIG AP for CYPROHEPTADINE HYDROCHLORIDE (CYPROHEPTADINE HYDROCHLORIDE)